ACCEPTANCE OF SWITCH, PATIENT SATISFACTION AND ADVERSE EVENTS AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR SB5 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A REAL-LIFE SETTING
Thomas De Somer 1
Nele Deprez
Didier Baert
Mieke Deceuninck 2
Inge Huys
Veerle Mattens 3
An Sterckx
Stijn Vanden Branden
Erik Vanderstraeten
Jo Vandervoort
Nina Van Heddegem
Pieter Dewint
1 AZ Maria Middelares, Gent, Belgium
2 Sint Vincentius Ziekenhuis, Deinze, Belgium
3 OLV Ziekenhuis, Aalst, Belgium
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]